On Wednesday, medical device manufacturer Dexcom finally delivered its direct-to-Apple Watch functionality for the G7 CGM. Here's how it works. A constant glucose monitor (CGM) has historically worked ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom, Inc. DXCM recently unveiled its new state-of-the-art manufacturing facility located in Athenry, Co. Galway. With the ability to produce millions of Dexcom rtCGM sensors annually, the new plant ...
KUALA LUMPUR: US-based DexCom Inc (Dexcom) will be setting up its first continuous glucose monitoring (CGM) systems manufacturing facility outside of the United States at the Batu Kawan Industrial ...
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eighteen brokerages that are presently covering the firm, Marketbeat reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback